Eton Bioscience
Generated 5/9/2026
Executive Summary
Eton Bioscience is a privately held biotechnology company based in San Diego, California, offering a comprehensive range of research services and products to the global life sciences community. Since its founding in 2003, the company has specialized in DNA sequencing, oligo synthesis, plasmid DNA preparation, and custom services such as gene synthesis, mutagenesis, and antibody production. Serving both academic and industrial research institutions, Eton Bioscience operates from multiple U.S. branch locations, ensuring broad accessibility and reliable turnaround times for clients. The company's consistent presence in the genetics and genomics sector positions it as a steady contributor to foundational research and development activities, though its private status and lack of disclosed financials suggest a stable but non-high-growth profile.
Upcoming Catalysts (preview)
- TBDLaunch of Next-Generation Sequencing Services60% success
- TBDExpansion into New Geographic Markets40% success
- TBDAcquisition by Larger Life Sciences Tools Company30% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)